A bacteriophage journey at the European Medicines Agency
نویسندگان
چکیده
P.H.A.G.E., Queen Astrid Military Hospital, Lab. for Molecular and Cellular Technology (LabMCT) Bruynstraat 1, 1120 Brussels, Belgium ∗Corresponding author: Leibniz Institute, DSMZ, Inhoffenstr. 7B, Braunschweig 38124, Germany. Tel: (49)-531-2616-220; Fax: (49)-531-2616-418; E-mail: [email protected] One sentence summary: The seriously and globally increasing bacterial multi-drug resistance calls out on concerted counteractive measures: international health authorities give consideration to the therapeutical use of bacteriophage therapy. Editor: Andrew Millard